Localized passivity breakdown of iron in chlorate- and perchlorate-containing sulphuric acid solutions: A study based on current oscillations and a point defect model

Autor: Pagitsas, M., Pavlidou, M., Sazou, D.

Publikováno v: In Electrochimica Acta 2008 53(14):4784-4795

The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner.

Autor: Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pavlidou M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pattarini L; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Morales-Kastresana A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Gallou C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Richter M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Lelievre H; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Scholer-Dahirel A; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Bossenmaier B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Sancerne C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Riviere M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Grandclaudon M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Zettl M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Blanc V; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 02; Vol. 28 (15), pp. 3387-3399.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fratture di tibia al ginocchio

Autor: Berizzi, Antonio, Pavlidou, M, Aldegheri, Roberto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::0a90513c2832b246e17759a0b2a9d323
http://hdl.handle.net/11577/100081

Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity.

Autor: Rubio-Pérez, Laura^1,2,3,4 (AUTHOR) laura.rubio.imas12@h12o.es, Frago, Susana⁵ (AUTHOR) susana.frago@leadartis.com, Compte, Marta⁵ (AUTHOR) marta.compte@leadartis.com, Navarro, Rocío⁵ (AUTHOR) rocio.navarro@leadartis.com, Harwood, Seandean L.⁶ (AUTHOR) sdlh@mbg.au.dk, Lázaro-Gorines, Rodrigo^1,2,3 (AUTHOR) rlazaro@cnio.es, Gómez-Rosel, Marina^1,2,3 (AUTHOR) marinagomezrosel.imas12@h12o.es, Hangiu, Oana^1,2,5 (AUTHOR) oana.hangiu@leadartis.com, Silva-Pilipich, Noelia^7,8 (AUTHOR) nsilva.1@alumni.unav.es, Vanrell, Lucía^9,10 (AUTHOR) lvanrell@unav.es, Smerdou, Cristian^7,8 (AUTHOR) csmerdou@unav.es, Álvarez-Vallina, Luis^1,2,3,4 (AUTHOR) lav.imas12@h12o.es

Publikováno v: Antibodies (2073-4468). Jun2024, Vol. 13 Issue 2, p34. 13p.